Quotient Wealth Partners LLC Sells 533 Shares of Axon Enterprise, Inc $AXON

Quotient Wealth Partners LLC decreased its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 64.0% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 300 shares of the biotechnology company’s stock after selling 533 shares during the quarter. Quotient Wealth Partners LLC’s holdings in Axon Enterprise were worth $248,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of AXON. TCTC Holdings LLC boosted its position in shares of Axon Enterprise by 75.0% during the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after acquiring an additional 24 shares during the last quarter. Bartlett & CO. Wealth Management LLC boosted its position in shares of Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock worth $31,000 after acquiring an additional 33 shares during the last quarter. Banque Transatlantique SA bought a new position in shares of Axon Enterprise during the first quarter worth $31,000. Catalyst Capital Advisors LLC bought a new position in shares of Axon Enterprise during the first quarter worth $32,000. Finally, Flaharty Asset Management LLC purchased a new stake in Axon Enterprise during the first quarter valued at $33,000. Institutional investors own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

AXON has been the topic of a number of recent research reports. Morgan Stanley set a $885.00 price target on shares of Axon Enterprise and gave the company an “overweight” rating in a research note on Friday, July 11th. Wolfe Research initiated coverage on shares of Axon Enterprise in a research note on Monday, July 7th. They set an “outperform” rating on the stock. Needham & Company LLC reaffirmed a “buy” rating and set a $870.00 price target on shares of Axon Enterprise in a research note on Wednesday, September 24th. Raymond James Financial reaffirmed an “outperform” rating and set a $855.00 price target (up previously from $645.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Finally, JPMorgan Chase & Co. upped their price target on shares of Axon Enterprise from $730.00 to $850.00 and gave the company an “overweight” rating in a research note on Thursday, July 17th. Fourteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $841.64.

Insiders Place Their Bets

In related news, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $713.74, for a total value of $7,137,400.00. Following the transaction, the chief executive officer owned 3,033,982 shares of the company’s stock, valued at $2,165,474,312.68. This trade represents a 0.33% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Jeri Williams sold 100 shares of the firm’s stock in a transaction dated Thursday, September 11th. The stock was sold at an average price of $752.54, for a total transaction of $75,254.00. Following the completion of the transaction, the director directly owned 1,416 shares in the company, valued at $1,065,596.64. This represents a 6.60% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 59,932 shares of company stock valued at $45,115,616. 5.70% of the stock is currently owned by company insiders.

Axon Enterprise Trading Up 2.8%

Shares of AXON opened at $670.68 on Monday. Axon Enterprise, Inc has a twelve month low of $422.38 and a twelve month high of $885.91. The company has a market cap of $52.65 billion, a P/E ratio of 165.60, a P/E/G ratio of 26.04 and a beta of 1.41. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The company’s fifty day simple moving average is $739.44 and its 200-day simple moving average is $719.61.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The business had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. During the same quarter in the prior year, the firm posted $1.20 earnings per share. The business’s revenue for the quarter was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.